Qualigen Therapeutics Inc logo

Qualigen Therapeutics Inc

NAS:QLGN (USA)   Ordinary Shares
$ 0.40 0 (0%) 11:09 PM EST
At Loss
Enterprise V:
$ 831.00K
Volume:
79.53K
Avg Vol (2M):
67.16K
Also Trade In:
Volume:
79.53K
At Loss
Avg Vol (2M):
67.16K

Business Description

Qualigen Therapeutics Inc logo
Qualigen Therapeutics Inc
NAICS : 541713 SIC : 8731
ISIN : US74754R2022

Share Class Description:

QLGN: Ordinary Shares
Description
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. It is a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. The Company has viewed its operations and managed its business in one segment operating mainly within the United States and Israel.
Name Current Vs Industry Vs History
Cash-To-Debt 2.49
Equity-to-Asset -0.38
Debt-to-Equity -0.51
Debt-to-EBITDA -0.05
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -51.53
Distress
Grey
Safe
Beneish M-Score -10.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate 9.82
Name Current Vs Industry Vs History
5-Day RSI 64.59
9-Day RSI 50.42
14-Day RSI 44.89
6-1 Month Momentum % -52.05
12-1 Month Momentum % -47.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.58
Quick Ratio 0.58
Cash Ratio 0.35
Days Inventory 77.71
Days Sales Outstanding 26.22
Days Payable 59.48

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -16.65

Financials

QLGN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:QLGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Qualigen Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.218
EPS (TTM) ($) -3.74
Beta -0.05
Volatility % 42.77
14-Day RSI 44.89
14-Day ATR ($) 0.040238
20-Day SMA ($) 0.394465
12-1 Month Momentum % -47.19
52-Week Range ($) 0.33695 - 1.26
Shares Outstanding (Mil) 5.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Qualigen Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Qualigen Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Qualigen Therapeutics Inc Frequently Asked Questions

What is Qualigen Therapeutics Inc(QLGN)'s stock price today?
The current price of QLGN is $0.40. The 52 week high of QLGN is $1.26 and 52 week low is $0.34.
When is next earnings date of Qualigen Therapeutics Inc(QLGN)?
The next earnings date of Qualigen Therapeutics Inc(QLGN) is .
Does Qualigen Therapeutics Inc(QLGN) pay dividends? If so, how much?
Qualigen Therapeutics Inc(QLGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1